Skip to main content
Top
Published in: Respiratory Research 1/2008

Open Access 01-12-2008 | Research

Accuracy of diagnostic registers and management of chronic obstructive pulmonary disease: the Devon primary care audit

Authors: Rupert CM Jones, Maria Dickson-Spillmann, Martin JC Mather, Dawn Marks, Bryanie S Shackell

Published in: Respiratory Research | Issue 1/2008

Login to get access

Abstract

Background

Guidelines on COPD diagnosis and management encourage primary care physicians to detect the disease at an early stage and to treat patients according to their condition and needs. Problems in guideline implementation include difficulties in diagnosis, using spirometry and the disputed role of reversibility testing. These lead to inaccurate diagnostic registers and inadequacy of administered treatments. This study represents an audit of COPD diagnosis and management in primary care practices in Devon.

Methods

Six hundred and thirty two patients on COPD registers in primary care practices were seen by a visiting Respiratory Specialist Nurse. Diagnoses were made according to the NICE guidelines. Reversibility testing was carried out either routinely or based on clinical indication in two sub-samples. Dyspnoea was assessed. Data were entered into a novel IT-based software which computed guideline-based treatment recommendations. Current and recommended treatments were compared.

Results

Five hundred and eighty patients had spirometry. Diagnoses of COPD were confirmed in 422 patients (73%). Thirty nine patients were identified as asthma only, 94 had normal spirometry, 23 were restrictive and 2 had a cardiac disorder. Reversibility testing changed diagnosis of 11% of patients with airflow obstruction, and severity grading in 18%. Three quarters of patients with COPD had been offered practical help with smoking cessation. Short and long-acting anticholinergics and long acting beta-2 agonists had been under-prescribed; in 15–18% of patients they were indicated but not received. Inhaled steroids had been over-prescribed (recommended in 17%; taken by 60%), whereas only 4% of patients with a chronic productive cough were receiving mucolytics. Pulmonary rehabilitation was not available in some areas and was under-used in other areas.

Conclusion

Diagnostic registers of COPD in primary care contain mistakes leading to inaccurate prevalence estimates and inappropriate treatment decisions. Use of pre-bronchodilator readings for diagnosis overestimates the prevalence and severity in a significant minority, thus post bronchodilator readings should be used. Management of stable COPD does often not correspond to guidelines. The IT system used in this study has the potential to improve diagnosis and management of COPD in primary care.
Literature
1.
go back to reference Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, Conway WA Jr, Enright PL, Kanner RE, O'Hara P: Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994, 272:1497–1505.CrossRefPubMed Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, Conway WA Jr, Enright PL, Kanner RE, O'Hara P: Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994, 272:1497–1505.CrossRefPubMed
3.
go back to reference Britton M: The burden of COPD in the U.K.: results from the Confronting COPD survey. Respir Med 2003,97(Suppl C):S71-S79.CrossRefPubMed Britton M: The burden of COPD in the U.K.: results from the Confronting COPD survey. Respir Med 2003,97(Suppl C):S71-S79.CrossRefPubMed
4.
go back to reference Jones R: Can early diagnosis and effective management combat the irresistible rise of COPD? Br J Gen Pract 2006,56(530):652–654.PubMedPubMedCentral Jones R: Can early diagnosis and effective management combat the irresistible rise of COPD? Br J Gen Pract 2006,56(530):652–654.PubMedPubMedCentral
5.
go back to reference National Collaborating Centre for Chronic Conditions: Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004,59(Suppl 1):1–232. National Collaborating Centre for Chronic Conditions: Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004,59(Suppl 1):1–232.
6.
go back to reference Global Initiative for Chronic Obstructive Lung Disease: Global strategy for the diagnosis, management and prevention of COPD. 2006. Global Initiative for Chronic Obstructive Lung Disease: Global strategy for the diagnosis, management and prevention of COPD. 2006.
7.
go back to reference Schermer TR, Jacobs JE, Chavannes NH, Hartman J, Folgering HT, Bottema BJ, van Weel C: Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD). Thorax 2003, 58:861–866.CrossRefPubMedPubMedCentral Schermer TR, Jacobs JE, Chavannes NH, Hartman J, Folgering HT, Bottema BJ, van Weel C: Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD). Thorax 2003, 58:861–866.CrossRefPubMedPubMedCentral
8.
go back to reference Eaton T, Withy S, Garrett JE, Mercer J, Whitlock RM: Spirometry in primary care practice; the importance of quality assurance and the impact of spirometry workshops. Chest 1999, 116:416–423.CrossRefPubMed Eaton T, Withy S, Garrett JE, Mercer J, Whitlock RM: Spirometry in primary care practice; the importance of quality assurance and the impact of spirometry workshops. Chest 1999, 116:416–423.CrossRefPubMed
9.
go back to reference Jones RCM, Freegard S, Reeves M, Hanney K, Dobbs F: The role of the practice nurse in the management of chronic obstructive pulmonary disease (COPD). Primary Care Respiratory Journal 2001, 10:106–108.CrossRef Jones RCM, Freegard S, Reeves M, Hanney K, Dobbs F: The role of the practice nurse in the management of chronic obstructive pulmonary disease (COPD). Primary Care Respiratory Journal 2001, 10:106–108.CrossRef
10.
go back to reference Lwin AM, McKinley RK: Management of COPD in Primary Care in Leicestershire. Primary Care Respiratory Journal 2005, 14:38–41.CrossRefPubMed Lwin AM, McKinley RK: Management of COPD in Primary Care in Leicestershire. Primary Care Respiratory Journal 2005, 14:38–41.CrossRefPubMed
11.
go back to reference White P, Wong W, Fleming T, Gray B: Primary care spirometry: test quality and the feasibility and usefulness of specialist reporting. Br J Gen Pract 2007,57(542):701–705.PubMedPubMedCentral White P, Wong W, Fleming T, Gray B: Primary care spirometry: test quality and the feasibility and usefulness of specialist reporting. Br J Gen Pract 2007,57(542):701–705.PubMedPubMedCentral
12.
go back to reference Johannessen A, Omenaas ER, Bakke PS, Gulsvik A: Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax 2005, 60:842–847.CrossRefPubMedPubMedCentral Johannessen A, Omenaas ER, Bakke PS, Gulsvik A: Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax 2005, 60:842–847.CrossRefPubMedPubMedCentral
13.
go back to reference Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM: Global burden of COPD: systematic review and meta-analysis. Eur Resp Journal 2006, 28:523–532.CrossRef Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM: Global burden of COPD: systematic review and meta-analysis. Eur Resp Journal 2006, 28:523–532.CrossRef
14.
go back to reference Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, Maslen TK: Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000, 320:1297–1303.CrossRefPubMedPubMedCentral Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, Maslen TK: Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000, 320:1297–1303.CrossRefPubMedPubMedCentral
15.
go back to reference Decramer M, Bartsch P, Pauwels R, Yernault JC: Management of COPD according to guidelines. A national survey among Belgian physicians. Monaldi Arch Chest Dis 2003,59(1):62–80.PubMed Decramer M, Bartsch P, Pauwels R, Yernault JC: Management of COPD according to guidelines. A national survey among Belgian physicians. Monaldi Arch Chest Dis 2003,59(1):62–80.PubMed
16.
go back to reference Roede BM, Bindels PJ, Brouwer HJ, Bresser P, de Borgie CA, Prins JM: Antibiotics and steroids for exacerbations of COPD in primary care: compliance with Dutch guidelines. Br J Gen Pract 2006,56(530):662–665.PubMedPubMedCentral Roede BM, Bindels PJ, Brouwer HJ, Bresser P, de Borgie CA, Prins JM: Antibiotics and steroids for exacerbations of COPD in primary care: compliance with Dutch guidelines. Br J Gen Pract 2006,56(530):662–665.PubMedPubMedCentral
17.
go back to reference Glaab T, Banik NRO, Wencker M: National survey of guideline-compliant COPD management among pneumologists and primary care physicians. COPD 2006, 3:141–148.CrossRefPubMed Glaab T, Banik NRO, Wencker M: National survey of guideline-compliant COPD management among pneumologists and primary care physicians. COPD 2006, 3:141–148.CrossRefPubMed
18.
go back to reference Ruse CE, Molyneux AW: A study of the management of COPD according to established guidelines and the implications for older patients. Age Ageing 2005, 34:299–301.CrossRefPubMed Ruse CE, Molyneux AW: A study of the management of COPD according to established guidelines and the implications for older patients. Age Ageing 2005, 34:299–301.CrossRefPubMed
19.
go back to reference Rutschmann OT, Janssens J-P, Vermeulen B, Sarasin FP: Knowledge of guidelines for the management of COPD: a survey of primary care physicians. Respir Med 2004, 98:932–937.CrossRefPubMed Rutschmann OT, Janssens J-P, Vermeulen B, Sarasin FP: Knowledge of guidelines for the management of COPD: a survey of primary care physicians. Respir Med 2004, 98:932–937.CrossRefPubMed
20.
go back to reference Tsagaraki V, Markantonis SL, Amfilochiou A: Pharmacotherapeutic management of COPD patients in Greece – adherence to international guidelines. Journal of Clinical Pharmacy and Therapeutics 2007, 31:369–374.CrossRef Tsagaraki V, Markantonis SL, Amfilochiou A: Pharmacotherapeutic management of COPD patients in Greece – adherence to international guidelines. Journal of Clinical Pharmacy and Therapeutics 2007, 31:369–374.CrossRef
21.
go back to reference Department of Health CMO: It takes your breath away. The impact of chronic obstructive pulmonary disease. London, Department of Health; 2004. Department of Health CMO: It takes your breath away. The impact of chronic obstructive pulmonary disease. London, Department of Health; 2004.
22.
go back to reference Hyland ME, Jones RCM, Hanney KE: The Lung Information Needs Questionnaire: Development, preliminary validation and findings. Respir Med 2006, 100:1807–1816.CrossRefPubMed Hyland ME, Jones RCM, Hanney KE: The Lung Information Needs Questionnaire: Development, preliminary validation and findings. Respir Med 2006, 100:1807–1816.CrossRefPubMed
23.
go back to reference American Thoracic Society and European Respiratory Society: Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004,23(6):932–946.CrossRef American Thoracic Society and European Respiratory Society: Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004,23(6):932–946.CrossRef
24.
go back to reference Fletcher CM, Elmes PC, Fairbairn AS, Wood CH: The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J 1959,2(5147):257–266.CrossRefPubMedPubMedCentral Fletcher CM, Elmes PC, Fairbairn AS, Wood CH: The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J 1959,2(5147):257–266.CrossRefPubMedPubMedCentral
25.
go back to reference Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF: Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 2003, 1:13.CrossRefPubMedPubMedCentral Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF: Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 2003, 1:13.CrossRefPubMedPubMedCentral
26.
go back to reference Anonymous: Beta2 agonist reversibility testing in COPD diagnosis. Drug Ther Bull 2005,43(12):89–91.CrossRef Anonymous: Beta2 agonist reversibility testing in COPD diagnosis. Drug Ther Bull 2005,43(12):89–91.CrossRef
27.
go back to reference British Thoracic Society, Scottish Intercollegiate Guideline Network: British guideline on the management of asthma. A national clinical guideline. Revised Edition. 2004. British Thoracic Society, Scottish Intercollegiate Guideline Network: British guideline on the management of asthma. A national clinical guideline. Revised Edition. 2004.
28.
go back to reference Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J: Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007, 356:775–789.CrossRefPubMed Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J: Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007, 356:775–789.CrossRefPubMed
29.
go back to reference Casaburi R, Kukafka D, Cooper CB, Witek TJ Jr, Kesten S: Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest 2005, 127:809–817.CrossRefPubMed Casaburi R, Kukafka D, Cooper CB, Witek TJ Jr, Kesten S: Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest 2005, 127:809–817.CrossRefPubMed
30.
go back to reference Celli B: Chronic Obstructive Pulmonary Disease. From unjustified nihilism to evidence-based optimism. Proc Am Thorac Soc 2006, 3:58–65.CrossRefPubMed Celli B: Chronic Obstructive Pulmonary Disease. From unjustified nihilism to evidence-based optimism. Proc Am Thorac Soc 2006, 3:58–65.CrossRefPubMed
31.
go back to reference Decramer M, Rutten-van MM, Dekhuijzen PN, Troosters T, van HC, Pellegrino R, van Schayck CP, Olivieri D, Del Donno M, De Backer W, Lankhorst I, Ardia A: Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial. Lancet 2005, 365:1552–1560.CrossRefPubMed Decramer M, Rutten-van MM, Dekhuijzen PN, Troosters T, van HC, Pellegrino R, van Schayck CP, Olivieri D, Del Donno M, De Backer W, Lankhorst I, Ardia A: Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial. Lancet 2005, 365:1552–1560.CrossRefPubMed
32.
go back to reference Tierney WM, Overhage JM, Murray MD, Harris LE, Zhou XH, Eckert GJ, Smith FE, Nienaber N, McDonald CJ, Wolinsky FD: Can computer-generated evidence-based care suggestions enhance evidence-based management of asthma and chronic obstructive pulmonary disease? A randomized, controlled trial. Health Serv Res 2005, 40:477–497.CrossRefPubMedPubMedCentral Tierney WM, Overhage JM, Murray MD, Harris LE, Zhou XH, Eckert GJ, Smith FE, Nienaber N, McDonald CJ, Wolinsky FD: Can computer-generated evidence-based care suggestions enhance evidence-based management of asthma and chronic obstructive pulmonary disease? A randomized, controlled trial. Health Serv Res 2005, 40:477–497.CrossRefPubMedPubMedCentral
Metadata
Title
Accuracy of diagnostic registers and management of chronic obstructive pulmonary disease: the Devon primary care audit
Authors
Rupert CM Jones
Maria Dickson-Spillmann
Martin JC Mather
Dawn Marks
Bryanie S Shackell
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2008
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-9-62

Other articles of this Issue 1/2008

Respiratory Research 1/2008 Go to the issue